|
|
|
Basic information
| Name |
Haramura Masayuki |
| Belonging department |
|
| Occupation name |
|
| researchmap researcher code |
R000011792 |
| researchmap agency |
Okayama University of Science |
Teacher Basic Information
Academic Society and Social Activity |
 |
Teacher Activity Information
|
|
- 2020/08/Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology Neurol Neuroimmunol Neuroinflamm/Fujihara K, Bennett J, de Seze J, Haramura M, Kleiter I, Weinshenker B, Yamamura T./Neurol Neuroimmunol Neuroinflamm
- 2019/06/Neuromyelitis optica spectrum disorder； Patient experience and quality of life/Beekman J, Keisler A, Pedraza O, Haramura M, Gianella-Borradori A, Katz E, Ratchford J, Barron G, Cook L, Behne J, Blaschke T, Smith T, Yeaman M./Neurol Neuroimmunol Neuroinflamm
- 2015/05/Identification and purification of target protein using affinity resin bearing a photo-label linker./Mabuchi K, Shimizu T, Haramura M, Tanaka A./Bioorg Med Chem Lett.
- 2011/09/Distinct cell surface proteome profiling by biotin labeling and glycoprotein capturing./Nagano K, Shinkawa T, Kato K, Inomata N, Yabuki N, Haramura M./J Proteomics.
- 2011/03/Integration of proteomic analyses to monitor the activity status of phosphorylation signaling./Nagano K, Shinkawa T, Yabuki N, Mutoh H, Inomata N, Watanabe Y, Ashihara M, Nagahashi S, Ishii N, Aoki Y, Haramura M./J Proteomics.
- 2010/01/Design and synthesis of peptidomimetic factor VIIa inhibitors./Shiraishi T, Kadono S, Haramura M, Kodama H, Ono Y, Iikura H, Esaki T, Koga T, Hattori K, Watanabe Y, Sakamoto A, Yoshihashi K, Kitazawa T, Esaki K, Ohta M, Sato H, Kozono T./Chem Pharm Bull (Tokyo).
- 2010/Selective elution of target protein from affinity resins by a simple reductant with a thiol group./Mabuchi M, Haramura M, Shimizu T, Nishizaki T, Tanaka A./Bioorg Med Chem Lett.
- 2009/A software program for more reliable precursor ion assignation from LC-MS analysis using LTQ ultra zoom scan./Shinkawa T, Nagano K, Inomata N, Haramura M./J Proteomics.
- 2009/Phosphoproteomic analysis of distinct tumor cell lines in response to nocodazole treatment./Nagano K, Shinkawa T, Mutoh H, Kondoh O, Morimoto S, Inomata N, Ashihara M, Ishii N, Aoki Y, Haramura M./Proteomics.
- 2009/Structure-based drug design of peptide mimetics containing large P3 moieties as inhibitors of factor Vlla./Shiraishi T, Kadono S, Haramura M, Kodama H, Ono Y, likura H, Esaki T, Koga T, Hattori K, Watanabe Y, Sakamoto A, Yoshihashi K, Kitazawa T, Esaki K, Ohta M, Sato H, Kozono T./Lett. Drug Des. Discovery.
- 2008/08/Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination./Shiraishi T, Kadono S, Haramura M, Kodama H, Ono Y, Iikura H, Esaki T, Koga T, Hattori K, Watanabe Y, Sakamoto A, Yoshihashi K, Kitazawa T, Esaki K, Ohta M, Sato H, Kozono T./Bioorg Med Chem Lett.
- 2007/02/Novel trifluoroacetophenone derivatives as malonyl-CoA decarboxylase inhibitors./Wallace DM, Haramura M, Cheng JF, Arrhenius T, Nadzan AM./Bioorg Med Chem Lett.
- 2007/Application of chemical biology to proteomics in drug target discovery./Masayuki Haramura
- 2006/03/Synthesis and structure-activity relationship of small-molecule malonyl coenzyme A decarboxylase inhibitors./Cheng JF, Chen M, Wallace D, Tith S, Haramura M, Liu B, Mak CC, Arrhenius T, Reily S, Brown S, Thorn V, Harmon C, Barr R, Dyck JR, Lopaschuk GD, Nadzan AM./J Med Chem.
- 2006/Reduction of nonspecific binding proteins to self-assembled monolayer on gold surface./Furuya M, Haramura M, Tanaka A. IF:/Bioorg Med Chem.
- 2006/Optimization of conditions for identification of proteins from SDS-PAGE analysis using LC-MS/MS./Higashiyama K, Tsuchiya K, Haramura M, Tanaka A.
- 2006/Structure of fipexide./Tanaka R, Haramura M, Tanaka A, Hirayama N./X-Ray Struct. Anal. Online,
- 2005/02/Structure-based design of P3 moieties in the peptide mimetic factor VIIa inhibitor./Kadono S, Sakamoto A, Kikuchi Y, Oh-eda M, Yabuta N, Yoshihashi K, Kitazawa T, Suzuki T, Koga T, Hattori K, Shiraishi T, Haramura M, Kodama H, Ono Y, Esaki T, Sato H, Watanabe Y, Itoh S, Ohta M, Kozono T./Biochem Biophys Res Commun.
- 2005/01/Novel interactions of large P3 moiety and small P4 moiety in the binding of the peptide mimetic factor VIIa inhibitor./Kadono S, Sakamoto A, Kikuchi Y, Oh-eda M, Yabuta N, Yoshihashi K, Kitazawa T, Suzuki T, Koga T, Hattori K, Shiraishi T, Haramura M, Kodama H, Ono Y, Esaki T, Sato H, Watanabe Y, Itoh S, Ohta M, Kozono T./Biochem Biophys Res Commun.
- 2005/Peptide mimetic factor Vlla inhibitor: Importance of hydrophilic pocket in S2 site to improve selectivity against thrombin./Kadono S, Sakamoto A, Kikuchi Y, Oh-eda M, Yabuta N, Koga T, Hattori K, Shiraishi T, Haramura M, Kodama H, Esaki T， Sato H, Watanabe Y, ltoh S, Ohta M, Kozono T./Lett. Drug Des. Discovery.
- 2005/Structure of etophylline./Tanaka R, Haramura M, Tanaka A, Hirayama N./X-Ray Struct. Anal. Online,
- 2005/Structure of flurandrenolide./Tanaka R, Haramura M, Tanaka A, Hirayama N./X-Ray Struct. Anal. Online,
- 2005/Structure of guanethidine monosulfate./Tanaka R, Haramura M, Tanaka A, Hirayama N./X-Ray Struct. Anal. Online,
- 2005/Structure of human factor VIIa/tissue factor in complex with a peptide-mimetic inhibitor: high selectivity against thrombin by introducing two charged groups in P2 and P4./Kadono S, Sakamoto A, Kikuchi Y, Oh-eda M, Yabuta N, Koga T, Hattori K, Shiraishi T, Haramura M, Kodama H, Ono Y, Esaki T, Sato H, Watanabe Y, Itoh S, Ohta M, Kozono T./Acta Crystallogr Sect F Struct Biol Cryst Commun.
- 2005/Structure of nadolol../Tanaka R, Haramura M, Tanaka A, Hirayama N./X-Ray Struct. Anal. Online,
- 2005/Structure of pimethixene./Tanaka R, Haramura M, Tanaka A, Hirayama N./X-Ray Struct. Anal. Online,
- 2005/Structure of trimetazidine./Tanaka R, Haramura M, Tanaka A, Hirayama N./X-Ray Struct. Anal. Online
- 2005/古くて新しいテーマ：アフィニティ樹脂による網羅的ターゲット探索～非特異的蛋白質の抑制～/原村昌幸、田中明人
- 2004/Crystal structure of carisoprodol./Horio K, Tanaka R, Akama H, Haramura M, Tanaka A, Akimoto T, Hirayama N./X-Ray Struct. Anal. Online,
- 2004/Crystal structure of dantrolene./Tanaka R, Akimoto T, Haramura M, Tanaka A, Hirayama N./X-Ray Struct. Anal. Online,
- 2004/Crystal structure of gefitinib./Tanaka R, Haramura M, Tanaka A, Hirayama N./X-Ray Struct. Anal. Online,
- 2004/Crystal structure of human factor VIIa/tissue factor in complex with peptide mimetic inhibitor./Kadono S, Sakamoto A, Kikuchi Y, Oh-eda M, Yabuta N, Koga T, Hattori K, Shiraishi T, Haramura M, Kodama H, Esaki T, Sato H, Watanabe Y, Itoh S, Ohta M, Kozono T./Biochem Biophys Res Commun.
- 2004/Crystal structure of hydroflumethazide./Tanaka R, Haramura M, Tanaka A, Hirayama N./X-Ray Struct. Anal. Online,
- 2004/Crystal structure of minoxidil./Akama H, Haramura M, Tanaka A, Akimoto T, Hirayama N./X-Ray Struct. Anal. Online,
- 2004/Crystal structure of nifenazone./Tanaka R, Horio K, Haramura M, Tanaka A, Hirayama N./X-Ray Struct. Anal. Online,
- 2004/Crystal structure of vigabatrin./Haramura M, Tanaka A, Akimoto T, Hirayama N./X-Ray Struct. Anal. Online,
- 2004/Crystal structure of2-(3-carboxypropyl)-6-(4-hydroxyphenyl)-3H-pyridazin-3-ylideneammonium bromide./Tanaka R, Haramura M, Tanaka A, Akimoto T, Hirayama N./X-Ray Struct. Anal. Online,
- 2003/11/Transport of amino acid-based prodrugs by the Na+- and Cl- -coupled amino acid transporter ATB0,+ and expression of the transporter in tissues amenable for drug delivery./Hatanaka T, Haramura M, Fei YJ, Miyauchi S, Bridges CC, Ganapathy PS, Smith SB, Ganapathy V, Ganapathy ME./J Pharmacol Exp Ther.
- 2003/Crystal structure of clobetasol propionate./Haramura M, Tanaka A, Akimoto T, Hirayama N./X-Ray Struct. Anal. Online,
- 2003/Crystal structure of dichlorphenamide./Haramura M, Tanaka A, Akimoto T, Hirayama N./X-Ray Struct. Anal. Online,
- 2003/Crystal structure of streptozocin/Haramura M, Tanaka A, Akimoto T, Hirayama N./X-Ray Struct. Anal. Online,
- 2002/06/Design and synthesis of novel tetra-peptide motilin agonists./Haramura M, Tsuzuki K, Okamachi A, Yogo K, Ikuta M, Kozono T, Takanashi H, Murayama E./Bioorg Med Chem
- 2002/01/Design and synthesis of motilin antagonists derived from the [1-4] fragment of porcine motilin./Haramura M, Okamachi A, Tsuzuki K, Yogo K, Ikuta M, Kozono T, Takanashi H, Murayama E./J Med Chem
- 2001/04/Quantitative structure-intestinal permeability relationship of benzamidine analogue thrombin inhibitor./Sugano K, Yoshida S, Takaku M, Haramura M, Saitoh R, Nabuchi Y, Ushio H./Bioorg Med Chem Lett
- 2001/01/Design and synthesis of N-terminal cyclic motilin partial peptides: a novel pure motilin antagonist./Haramura M, Okamachi A, Tsuzuki K, Yogo K, Ikuta M, Kozono T, Takanashi H, Murayama E./Chem Pharm Bull (Tokyo)
- 2001/Physicochemical parameters responsible for the affinity of methotrexate analogs for rat canalicular multispecific organic anion transporter (cMOAT/MRP2)./Han YH, Kato Y, Haramura M, Ohta M, Matsuoka H, Sugiyama Y./Pharm Res
- 1999/11/Structure-activity study of intact porcine motilin./Haramura M, Tsuzuki K, Okamachi A, Yogo K, Ikuta M, Kozono T, Takanashi H, Murayama E./Chem Pharm Bull (Tokyo)
- 1989/Chirarity transfer in the 1,5-hydride shift of stannyl compound having a cationic center at the gamma-position./Sato T, Haramura M, Taka N./Tetrahedron Lett.
Competitive research funds |
|
Other Research Achivements |
|
Educational Improvement Achievement |
|
On-campus Conference Management |
|
Off-campus Conference Management |
|
|
